Use of cytokines and mitogens to inhibit pathological immune responses
US7115259B2 · kind B2 · utility
1Cited by
5References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 27, 2003 |
| Grant date | Oct 3, 2006 |
| Priority date | — |
| Expiry date | Aug 27, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/599
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is generally related to methods of treating autoimmune diseases, including both antibody-mediated and cell-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.